WJB001

· Wigen Biomedicine Technology (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for WJB001, covering 2026-03-27 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors [Phase 1, Phase 2]